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The objective of this study was to determine the effects of dietary short and 
medium chain fatty acids in on the stress-induced inflammatory response using a 
murine lipopolysaccharide (LPS) model. It was hypothesized that a diet containing 
short and medium chain dietary fatty acids would be protective, in terms of survival, 
against lipopolysaccharide induced inflammation.  
Mice were fed a purified AIN-76A diet that either contained corn oil, anhydrous 
milk fat, a combination of corn oil with milk fat globule membrane or medium chain 
triglyceride oil, or a milk fat globule membrane and anhydrous milk fat combination 
(5% by weight). Diets were balanced to contain the approximately the same amount of 
macro- and micronutrients and only differ in fat source. After being on the diet for 7 
weeks, mice were challenged by intraperitoneal injection, with LPS (10 mg/kg) or 
saline. Primary endpoints for this experiment were: survival, intestinal permeability, 
production of proinflammatory cytokines, and histopathology of the large intestine.  
No significant differences were found with weight gain and body mass 




of LPS injection there was 0% survival of all mice across all diets. LPS challenge 
caused hyperpermeability of the gut compared to sham mice. Also, LPS challenge 
increased proinflammatory cytokines. In conclusion, the current data indicates that the 
addition of dietary fats that are high in short and medium chain fatty acids to a purified 












Sepsis is defined as the presence of an infection in combination with systemic 
inflammation in a host. One of the detrimental results of sepsis is multiple organ failure 
which eventually leads to death. Lipopolysaccharide (LPS), an endotoxin that can be 
found on the outer surface of gram-negative bacteria, can be used as a model for sepsis. 
LPS present in the circulatory system of hosts can induce symptoms that are seen in 
patients during septicemia.  
Previous studies have suggested that including milk fat in a diet may protect 
against a lethal dosage of LPS in rodents. Milk fat has a unique fatty acid composition 
in which approximately 20-30% is made up of short and medium chain fatty acids. 
Interestingly, studies have also indicated that medium chain triglyceride (MCT) oil can 
also have a protective effect against LPS induced inflammation. The objective of this 
research was to determine if these dietary fatty acids, would have any effect against 
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Sepsis is defined as the presence of an infection in combination with systemic 
inflammation in a host (Nguyen et al., 2006). One of the detrimental results of sepsis is 
multiple organ failure which eventually leads to death. Indicators of systemic 
inflammation include irregular body temperature ( >38ºC or < 36ºC), a high pulse rate 
(>90bpm), and either a very high or low white blood cell count (Nguyen et al., 2006). 
During sepsis, the host response begins to activate monocytes, macrophages, and 
neutrophils that interact with endothelial cells through numerous pathogen recognition 
receptors (Beutler, 2004). Furthermore, the cellular activation allows for the 
mobilization of plasma cytokines which include tumor necrosis factor, interleukins, and 
eicosanoids (Nguyen et al., 2006). The mechanism behind sepsis is unclear and there is 
currently no known preventative measure or treatment for the illness. However, recent 
studies have suggested that short and medium chain fatty acids may play a role in 
protecting against septicemia (Kono et al., 2003, Snow et al., 2011). One source of these 
types of saturated fatty acids is dairy fat. 
In the past, epidemiological data have linked the consumption of saturated fats 
to certain cardiovascular diseases such as coronary heart disease (Hu et al., 1999). 
However, in the last few years, scientists have begun to question whether dairy fats 
should be categorized with other sources of saturated fat, as more recent 
epidemiological studies suggest that dairy consumption is inversely related to 
metabolic diseases such as Type 2 diabetes (T2D) (Elwood et al., 2008, Tong et al., 
2011, Kalergis et al., 2013, Hirahatake et al., 2014). The idea that dairy fat may protect 
against the development of metabolic diseases is interesting since certain risk factors 




density lipoprotein cholesterol, elevated blood triglyceride levels, and increases in 
inflammatory markers, are a concern in the U.S. population (Ervin, 2009, Mozaffarian 
and Ludwig, 2015). Several different proposed mechanisms and pathways suggest that 
the protective effect from dairy fat comes from a multitude of sources which includes 
a calcium dependent pathway (Zemel, 2003a, b, Sun and Zemel, 2006, Sun and Zemel, 
2008), its role in preventing mitochondrial dysfunction (Sun and Zemel, 2007, 2009, 
Zemel and Zhao, 2009, Bruckbauer and Zemel, 2011, Li et al., 2012), and its supply of 
a bioactive lipid (trans-palmitoleate)(Mozaffarian et al., 2010, Mozaffarian et al., 
2013). Unlike most foods, dairy fat contains a relatively high amount of short and 
medium chain saturated fatty acids.  
Fatty acids are typically categorized by their carbon chain length and degree of 
unsaturation. Medium and short chain fatty acids are saturated fatty acids typically 4 to 
14 carbons long. Dairy fat contains this group of fatty acids along with other longer 
chain fatty acids. The fatty acids in bovine milk come from two sources: de novo 
synthesis or the diet. Medium and short chain fatty acids, which are present in milk fat 
at up to 10.9% (Månsson, 2008), are metabolized differently than longer chain fatty 
acids. The metabolism of fats begins in the intestine, where triglycerides are broken 
down to free fatty acids by pancreatic lipases and bile salts. Longer chain free fatty 
acids are reesterified into triglycerides and packed in chylomicron vesicles and are 
transported into the lymphatic and circulatory system. Unlike longer chained fatty 
acids, medium and short chain fatty acids act as free molecules that can be transported 
directly to the liver via the portal vein (Figure 1).  
The long-term goal of this proposed project is to investigate the potential health 
effects of short and medium chain fatty acids. This research will examine the roles of 




found in dairy fat and medium chain triglyceride oil (MCT) in a model for sepsis. If 
they are shown to have a protective effect, further studies of these dietary fats would be 





Figure 1. Metabolism of SCFA/MCFA. MCTs are more rapidly absorbed compared 
to longer chain triglycerides, which require a transport lipoprotein to pass through the 







Gut permeability, intestinal microflora, and Gut-Liver Axis 
It has been suggested that gut leakiness plays a role in allowing endotoxins to 
enter the blood and activate cellular macrophages, monocytes, and neutrophils (Rao, 
2009). A key component of the gastrointestinal tract is a layer of epithelial cells that 
separate the body from the external environment. The epithelial layer is one way the 
body ensures protection from a variety of environmental pathogens entering the blood 
capillary system and causing an immune response (Arrieta et al., 2006). Specifically, 
the small intestine epithelial cells regulate the transportation of materials between the 
lumen and extracellular space. The movement of molecules through the small intestine 
membrane can come from either transcellular transport, which relies on active 
transport, or movement through the paracellular space, which occurs solely via passive 
diffusion. The integrity of tight junctions between adjacent epithelial cells have been 
shown to regulate the amount of materials that can diffuse across the membrane (Arrieta 
et al., 2006, Anderson and Van Itallie, 2009). The permeability of the gut is especially 
important considering the gut microbiota and the number of microorganisms that can 
leave the lumen and enter the bloodstream.  
The gastrointestinal microflora is made up of a diverse community of 
microorganisms. The roles that the intestinal microflora can play include the production 
of short-chain fatty acids, synthesis of vitamins, and other metabolic contributions 
(Bentley and Meganathan, 1982, Canny and McCormick, 2008). The absence of 
intestinal microflora, shown in germ-free mice, causes the loss of these important 
metabolic functions (Wostmann, 1981).  However, the beneficial effects that come with 




gram-negative bacteria, which are found naturally in the gastrointestinal tract, is a 
glycolipid called Lipopolysaccharide (LPS) (Thurman, 1998). LPS, which has been 
shown to signal for the proinflammatory immune response and the cause of 
endotoxemia, can be found in the gut lumen (Van Deventer et al., 1988). The 
concentration of LPS increases in the gut during sepsis (Canny and McCormick, 2008), 
thus, compromise of the intestinal barrier would allow for the passage of more 
endotoxin into the bloodstream (Mei et al., 2016). The direct cause of gut leakiness is 
still unknown. Endotoxemia has been associated with gut leakiness which was linked 
to certain high-fat diets in obese patients (Rao, 2009, Zhong et al., 2015). Ethanol-
induced intestinal permeability in mice showed higher levels of plasma endotoxin, 
which was further exacerbated through oral administration of LPS (Lambert et al., 
2003). One of the targets of LPS is a CD14 LPS receptor that lies on the surface of 
macrophages in the liver (Kono et al., 2003).  
 Kupffer cells are one of the resident macrophages that reside in the liver. The 
main role of these cells is to remove endotoxins in the blood (Wheeler, 2003). In 
response to the removal of endotoxins, Kupffer cells release proinflammatory cytokines 
such as tumor necrosis factor-alpha (TNF-) (Dinarello, 2000). LPS has been shown 
to be signal dependent on the membrane bound CD14 receptor on Kupffer cells (Kono 
et al., 1998). Knockout of the receptor has been shown to slow the development of 
metabolic diseases, which further indicates the involvement of LPS in developing 
systemic inflammation (Cani et al., 2008). It has been reported that activated Kupffer 
cells can be inhibited by gadolinium chloride (GdCl3), a compound toxic to Kupffer 
Cells, thus preventing liver injury (Adachi et al., 1994). However, gadolinium chloride 
is not suitable for clinical use due to its toxicity. Therefore, a better mechanism for 




Diet and Inflammation 
Diet has been shown to play a crucial role in the development and treatment of 
chronic and acute inflammation in humans (Giugliano et al., 2006, Galland, 2010). 
Dietary fat is one of the macronutrients that can be directly linked to inflammation. For 
instance, a selection of important mediators of inflammation such as eicosanoids, 
prostaglandin E2, and leukotriene B4, are all derived from the precursor omega-6 (-
6) poly-unsaturated fatty acid (PUFA), arachidonic acid (AA) (James et al., 2000). AA 
is formed from the metabolism of linoleic acid, which is an essential fatty acid, through 
a series of elongation and desaturation (Nakamura et al., 2004). Existing evidence 
indicates that a diet with high dietary PUFAs concentration, depending on if it’s an 
omega-3 (-3) or -6 fatty acid, can either decrease or exacerbate the inflammatory 
responses. It was shown that biomarkers for inflammation such as proinflammatory 
cytokines TNF- are higher in mice that consume an -6 rich diet using corn oil, 
compared to an -3 enriched diet during infection (Ghosh et al., 2013). An increase in 
other proinflammatory cytokines such IL-1, IL-6, IL-2 and IFN- are commonly 
associated with linoleic acid rich diets due to arachidonic acid-derived eicosanoids 
(Calder, 2001). Furthermore, mice fed a high -6 diet had elevated levels of 
proinflammatory microbes in the gut and also severe intestinal damage during infection 
(Ghosh et al., 2013). In contrast to the abundance of data that exists for PUFAs and 
their roles in inflammation, little is known about the dietary fats in dairy and their 
potential effects on markers of inflammation.   
Milk Fat Globule Membrane  
One of the unique components of milk is the milk fat globule membranes 




from the rough endoplasmic reticulum, into the cytosol, with a phospholipid/cholesterol 
monolayer. As the fat droplet migrates through the apical membrane of the cell, it is 
coated with a triple phospholipid layer membrane, which consist of glycoproteins, 
cholesterol, and phospholipids, and proteins. Phospholipids such as sphingomyelin, 
phosphatidylcholine, and phosphatidylethanolamine, which comes from the membrane, 
make up approximately 30% of the total lipid content of milk fat globules (Black et al., 
1998, Cavaletto et al., 2008, Hernell et al., 2016). The phospholipids in MFGM have 
been shown to play a role in intestinal maturation, in which a decrease in lactase activity 
and vacuolated enterocytes, which are located along the villi of the intestinal wall, 
reflects the maturity of intestinal cells (Motouri et al., 2003). The beneficial effect it 
has on gut integrity and proliferation of epithelial cells is seen most prominently during 
the neonatal stages in animals and humans (Greenspon et al., 2009, Greenspon et al., 
2011). In a past study, a diet that consisted of fat coming from MFGM in combination 
with milk fat improved gut epithelial integrity and prevented hyper-permeability in 
mice during a state of acute inflammation induced by LPS (Snow et al., 2011). In this 
study, mice that had a diet with MFGM as a source of fat had a lower concentration of 
plasma fluorescence (which is used as an assessment of gut integrity) and survived 48 
hours after administration of a lethal dosage of LPS compared to the control group 
(Snow et al., 2011). It was suggested that the reduction in gut permeability ultimately 
protected the mice from death after being given a possibly lethal dosage of LPS by 
disallowing further release of inflammatory toxins that reside in the gut. Interestingly, 
a study with a similar experimental design in which medium chain triglyceride (MCT) 
oil was orally given to rats produced similar results in survival and intestinal 
permeability. An increase in survival was seen as dose response to MCT and a decrease 




rats that had supplemented MCT oil (Kono et al., 2003). A dosage of 5g/kg of MCT 
oil, was shown to be effective in preventing septic shock in this study. The similar result 
between these two studies brings into consideration the possibility that the protective 
effects from both diets comes from the similar fatty acid composition of the diets.  
Short and Medium Chain Fatty acids  
The production of short and medium chain fatty acids in dairy fat (which are 
products of microbial activity in the rumen) has long been studied (McGuire and 
Bauman, 2002, Parodi, 2009). The amount of saturated fatty acids make up 
approximately 70% of the total weight of the fat in milk (Månsson, 2008). Of the 
saturated fatty acids, about 11% are short chain fatty acids (SCFA) (Månsson, 2008). 
SCFA are typically esterified at the sn-3 position on a triglyceride (Månsson, 2008). 
When consumed by humans, milk triglycerides are digested by lipases in the stomach. 
The preference for hydrolyzing at the sn-3 position of the triglyceride by lipases allows 
for the release of the SCFA (Månsson, 2008). More specifically, dietary fats, more 
specifically in the form of long-chain fatty acids, once hydrolyzed, are absorbed in 
mixed micelles and are transported in chylomicrons (Kono et al., 2003). Unlike long-
chain fatty acids, short and medium chains fatty acids can be absorbed and transported 
directly to the liver via the portal vein, where they are used for energy (Kono et al., 
2003). In one study, the metabolism of butyrate was shown to provide a positive effect 
in an animal model by systemically reducing the expression of high-mobility group box 
protein 1 (HMGB1) and also significantly increasing the survival rate of the treated 
group compared to control during septic shock (Zhang et al., 2007). This positive effect 
could be due to the direct absorption of the SCFA into the liver.  
A series of studies have indicated that medium-chain triglyceride diets may 




supplemented with MCTs have been shown to suppress early alcohol-induced liver 
injury, proinflammatory cytokines in endotoxin-challenged mice, and intestinal 
inflammation in both animal and cell culture models (Hoshimoto et al., 2002, Mañé et 
al., 2009, Carlson et al., 2015, Geng et al., 2016). It was reported that dietary MCTs 
prevented alcoholic liver injury by inhibiting the activation of Kupffer cells (Kono et 
al., 2003). It has also been shown that diets supplemented with MCTs improve glucose 
tolerance in rats and diabetic patients, which suggests that MCTs may have anti-
diabetic benefits (Han et al., 2007, Terada et al., 2012). Findings from Kono et al. 
(2003) have suggested that medium chain fatty acids play a direct role in inhibiting the 
production of proinflammatory cytokines, which protects mice from septic shock and 
death, through the down-regulation of macrophage surface receptor CD14 found in the 
liver when given a lethal dosage of an endotoxin.  
Overview 
 Both MCT and MFGM have a protective effect against mediators of sepsis. 
What is missing in the literature is evidence that links these two entities together. 
Therefore, this proposed study will evaluate the roles of short and medium chain fatty 
acids in dairy fat and medium chain triglyceride oil. By using an animal model of sepsis, 












THE EFFECTS OF DIETARY MILK FAT AND MEDIUM CHAIN 
TRIGLYCERIDE OIL DURING AN INFLAMMATORY REPONSE 
 
The hypothesis of this proposed research is: 
A purified diet with a fat composition coming from short and medium chain fatty 
acids from dairy fat or medium chain triglyceride will protect against acute 
inflammation induced by lipopolysaccharide. 
 
The objective of this proposed research is: 
1) Establish an animal model to determine the effects of dietary fatty acids on the 







For this study, five purified diets varied only in fat composition were formulated 
(Envigo Teklad Diets, Madison, WI USA). The diets were based on the American 
Institute of Nutrition -76A (AIN-76A) diet, which has a 5% by weight basis for its 
dietary fat (Table 2). The macro- and micronutrients in the diets were adjusted to be 
equivalent (Table 1). Each diet only differed in its type of dietary fat: corn oil (CO), 
medium chain triglyceride oil + corn oil (MCT+CO), anhydrous milk fat (AMF), milk 
fat globule membrane + corn oil (MFGM+CO), or milk fat globule membrane + 
anhydrous milk fat (MFGM+AMF). The milk fat globule membrane isolates diet was 
formulated previously in the Ward lab(Snow et al., 2011) in which 125 grams of the 
isolate were used to have approximately 10% of the fat as phospholipid and the other 
half being anhydrous milk fat (MFGM/AMF) which was shown to have a protective 



































Protein (g/kg of diet)      
Casein 183 183 183 103 103 
Whey Protein Isolate 17 17 17 - - 
DL-Methionine 3 3 3 3 3 
Carbohydrate (g/kg of diet) 
Sucrose 494.9 494.9 494.9 494.9 494.9 
Cellulose 50 50 50 50 50 
Lactose, monohydrate 5 5 5 5 5 
Corn Starch 150 150 150 150 150 
Fat      
Corn Oil 50 25 - 25 - 
Medium Chain Triglyceride 
Oil 
- 25 - - - 
Anhydrous Milkfat - - 50 - 25 
MFGM Powder - - - 125 125 
Vitamins and minerals (g/kg of diets) 
Mineral Mix 35 35 35 35 35 
Vitamin Mix 10 10 10 10 10 
Choline Bitartrate 2 2 2 2 2 
Ethoxyquin, antioxidant 0.01 0.01 0.01 0.01 0.01 
 



















Protein 17.8 17.8 17.8 17.8 17.8 
Carbohydrate 64.9 64.9 64.9 64.9 64.9 






Mice Study 1 
Animals and Preliminary Measures 
BALB/c mice were randomly assigned to each diet (n=12) for 6 weeks. The 
preliminary measures during this stage of the experiment included monitoring for 
weight changes in the animal, body composition using Magnetic Resonance Imaging 
(MRI), and glucose sensitivity by oral glucose tolerance test (OGTT). Weight was 
measured weekly during the 6-week diet treatment. Body composition was measured 
twice, at baseline prior to treatment and at terminal, before LPS challenge.  
Oral Glucose Tolerance Test 
An OGTT was conducted at the end of the 6-week treatment period before the 
LPS challenge. OGTT was done by using a glucose monitoring system from a local 
medical supplier. A stock solution of 200 mg/mL was made. Mice were gavaged with 
a total of 2 g glucose/kg bodyweight. Blood was retrieved from the tail-end of the 
animal via tail snip. Six mice were randomly selected from each group for this 
procedure. Glucose was measured in triplicate at baseline, 15, 30, 60, 90, and 120 
minutes, post glucose gavage.  
Lipopolysaccharide Challenge  
After 6 weeks, mice were injected (i.p.) with 10mg LPS/kg body weight to 
induce septic shock. Six hours after LPS challenge, mice were sacrificed by CO2 
asphyxiation and cardiac puncture. Serum, colon, liver, skeletal muscle, and visceral 
adipose were collected and flash frozen. The remaining were monitored for 48 hours 






Figure 2. Experimental design for mouse study 1. Mice (n=12) were divided into two 
groups with an n=6 in each group. Mice that underwent an OGTT were selected as the 
sacrificed group after LPS was challenged. This selection method was used to ensure 
that the same treatment was conducted on each mouse within both groups. Six hours 
after the challenge, samples were collected.  
Evaluation of gut barrier integrity in mice and colon inflammation 
Mice that were assigned to be sacrificed were gavage with Fluorescein 
Isothiocyanate –dextran (FITC-dextran ~4,000 Da) (600mg/kg body weight, 
60mg/mL) to assess gut permeability. The oral gavage of FITC-dextran was performed 
at the same time as the LPS injection, 6 hours prior to sacrifice. FITC-dextran recovered 
in the blood plasma was analyzed using a fluorescence plate reader at (excitation) 
=493 nm and (emission) = 517 nm. and was used to assess the integrity of the gut in 
the animals.  
Colons were cleaned with 1X PBS, fixed with 70% ethanol and then Swiss-
rolled for storage for 24h in 10% formalin. After 24h of storage, 10% formalin was 
replaced with 70% ethanol for final storage before histological analysis. Colons were 
evaluated for inflammatory changes using a histologic scoring system described for 
mouse small intestine (Rees, 1998, Burns et al., 2001). An overall inflammatory score 
was given to each tissue which indicated the extent of lesions and inflammation.  
BALB/c
(n=48)
Monitor for survival (48 
hours)
(n=24)
Sacrificed after 6 hours of 
challenge
(n=24) 
Necropsy for blood 
samples and organs are 
collected  for evaluation 





A completely randomized design was used to evaluate the response of dietary 
milk fat or medium chain triglyceride oil on mice when challenged with LPS. Shapiro-
Wilk normality test was used to determine if data points were normally distributed. A 
log-transformation was used for data points that were not normally distributed. Tukey’s 
multiple comparisons were used for posthoc analysis. The analysis was performed with 
GraphPad Software Prism 7 (GraphPad Software Inc., La Jolla, CA USA). Data is 






Body Weight, Mass, and Food Intake 
After being on the diet for 6 weeks, there were no significant differences 
between the four groups. Lean and fat body mass were measured at baseline and at the 
end. Feed efficiency was calculated as a ratio of the total food intake over kilocalories 




Figure 3. Weight and food intake measurements. An n=12 is assigned per group. A) 
Change in body weight monitored for 6 weeks. No differences were seen after 6 weeks 




intake over total kilocalories. C) and D) No significant differences were seen after 6 
weeks on the diet. 
Oral Glucose Tolerance Test 
A measure of fasting glucose and an oral glucose tolerance test was conducted 
to evaluate glucose sensitivity. The results indicate that a diet consisted of either milk 
fat or MCT oil does not have any significant effect on glucose sensitivity relative to a 
corn oil base diet.   
 
 
Figure 4. Fasting glucose measurement and OGTT. Diet effect on fasting glucose and 
glucose tolerance. An n=12 is assigned per group. A) Mean in concentration of 
milligram per deciliter. Glucose measurements were taken during fasting prior to 
OGTT. B) Area under the curve was calculated by the sum each area calculated by each 
time point. (Baseline, 15min, 30min, 60min, 90min, and 120min). Triplicate 
measurements of glucose concentration were made for each time point.  
Survival  
After LPS injection, mice were monitored for 48h for survival. Within the first 
16h following the injection, mice on the CO, AMF, MCT+CO, and MFGM+CO groups 
began to die due to the LPS challenge. In less than 24h, 90% of the animals had died. 






Figure 5. Survival plot. An n=6 was assigned per group. Animals were monitored 
everything 2-4 hours for 48h.  
Intestinal inflammation and epithelial cell permeability 
Histological analysis revealed no differences in colon histology scores for mice 
on CO, AMF, MCT+CO, and MFGM+CO diets. The lesions in these mice consisted of 
lymphocyte infiltration and aggregates within the submucosa and deep mucosa. The 
colonic crypt and epithelium were intact. Since the mice in these groups did not survive, 
it was expected to see a high score. There was no protective effect against intestinal 












Figure 6. Gut permeability and inflammation measurements. Effect of diets on 
fluorescence and colon inflammation after LPS challenge. An n=6 is assigned per 
group. A) Data are log10 transformed mean nanogram per milliliter. B) Inflammation 
parameters were summed together and then multiplied by a factor reflecting the 
percentage of the colon involved (0–25% (1), 26–50% (2), 51–75% (3), and 76–100% 
(4), to obtain the overall score (up to 24). Severity and distribution were separately 
assessed and combined into one score. Colon tissues of mice that were on the 
MFGM+AMF diet that survived LPS challenge, were also submitted for histology. 







Mice Study 2 
Changes in dietary medium chain fatty acids in MCT+CO diet 
Fatty acid composition analysis using gas chromatography on the diets detected 
Capric acid (C10:0) in the MCT+CO diet. Previously, it was suggested that the 
protective effect of medium chain fatty acids was due to Caprylic acid (C8:0) being in 
the diet(Kono et al., 2003). As a result, for the second mice study, an isolated form of 
the medium chain triglyceride oil, which only contained C8:0 was used to formulate 
the MCT+CO diet.  
Animals and Preliminary Measures 
For this study, BALB/c mice were used (n=90). Mice were randomly assigned 
to each diet (n=18) but were group housed in triplicates for 7 weeks. The preliminary 
analyses during this stage of the experiment included monitoring for weight changes in 
the animal, lean body mass and fat mass using MRI, and glucose sensitivity. Weight 
was measured weekly during the 7-week treatment. Body composition was measured 
twice, at baseline prior to treatment and at terminal, before LPS challenge.  
Lipopolysaccharide and Sham Challenge  
After 7 weeks, mice were injected (i.p.) with 10mg LPS/kg body weight to 
induce septic shock (n=60). Mice that previously underwent an OGTT (n=30) were 
given Sham injections. Of the total n=60 LPS challenged mice, n=30 were used for 
survival analysis. Survival was monitored for 48h. Six hours after the challenge, both 
Sham (n=30) and the remaining LPS (n=30) challenged mice were sacrificed by CO2 
asphyxiation and cardiac puncture and serum, small and large intestines, and liver was 








Figure 7. Experimental design for mice study 2. Mice (n=90) will be divided into two 
groups with survival group having a total of 30 sample size (n=6 per diet group) and a 
total of 60 samples for the sacrificed group. 6 hours after challenge, sample collection 
will occur for the sacrificed animal.  
Evaluation of gastrointestinal and hepatic inflammation   
Intestinal tissue was cleaned with 1X PBS, fixed with 70% ethanol and then 
Swiss-rolled for storage for 24h in 10% formalin. After 24h of storage, 10% formalin 
was replaced with 70% ethanol for final storage before histological analysis. Sections 
of ileum, jejunum, colon, and liver were evaluated for inflammatory changes using a 
histologic scoring system described for mouse small intestine (Rees, 1998, Burns et al., 
2001). An overall inflammatory score was given to each tissue which indicated the 
extent of lesions and inflammation.  
Analysis of proinflammatory cytokines in blood serum   
Pro-inflammatory cytokines such as TNF-a, interleukin 1 (&), 12, and 18 are 
released during an immune response (Netea et al., 2003). Previously, both MCT (Kono 
et al., 2003) and MFGM (Snow et al., 2011) treatment resulted in a log reduction in the 
concentration of these pro-inflammatory cytokines; thus, it is important to measure 
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cytokine production for this study as well in order to see observe any similar findings. 
Sixteen different cytokines were measured in serum using a Quansys-multiplex plate 
reader:  IL-1m IL-1, IL-2, IL-3, IL-4, IL5, IL6, IL-10, IL-12p70, IL-17, MCP-1, 
IFN-, TNF-, MIP-1, GM-CSF, and RANTES. It has been shown that LPS has a 
negative effect on gut integrity and increases the concentration of proinflammatory 







A 2x2 factorial design was used to evaluate the response of dietary milk fat or 
medium chain triglyceride oil on mice when challenged with LPS or Sham. Shapiro-
Wilk normality test was used to determine if data points were normally distributed. A 
log-transformation was used for data points that were not normally distributed. Tukey’s 
multiple comparisons was used for posthoc analysis. The analysis was performed with 
GraphPad Software Prism 7 (GraphPad Software Inc., La Jolla, CA USA). Data is 







Body Weight, Mass, and Food Intake 
Mice were fed the treatment diets for 7 weeks. Results indicated no significant 
differences (P > 0.05) between diet groups in terms of body weight, feed efficiency, 
and body mass.  
 
Figure 8. Weight and food intake measurements. An n=6 is assigned per group. A) 
Change in body weight monitored for 7 weeks. No significant differences were seen 
after 7 weeks of diet treatment. B) Feed efficiency was calculated as a ratio of the 
cumulative food intake over total kilocalories. C) and D) No significant differences 










Oral Glucose Tolerance Test 
Contrary to what was seen previously in the preliminary study, blood glucose 
concentration during fasting was not significantly different for mice on the 
MFGM+AMF diet compared to other diets. Similarly, there were no significant 
differences seen in any diet groups in terms of glucose tolerance.  
 
Figure 9. Fasting glucose measurements and OGTT. Diet effect on fasting glucose and 
glucose tolerance. A) Mean in concentration of milligram per deciliter. B) Area under 
the curve was calculated by the sum each area calculated by each time point. (Baseline, 
15min, 30min, 60min, 90min, and 120min). Triplicate measurements of glucose 
concentration were made for each time point.  
Survival 
After LPS challenge, the survival of the groups was monitored for 48h. Within 
18h, mice from the MCT+CO and AMF diets began to succumb to death from the LPS 
challenge. At 24h, none of the mice fed with MCT+CO, AMF, MFGM+CO, and 






Figure 10. Survival plot. An n=6 is assigned per group. Animals were monitored 
everything 2-4 hours for 48h.  
Intestinal inflammation and epithelial cell permeability 
 Although data are not presented here, histology conducted on the small 
intestine, colon, and liver indicated that there were no significant differences seen in 
the overall inflammation in these tissues. Surprisingly, there were no differences 
between Sham and LPS treated mice. No significant differences in FITC-Dextran 
concentration were seen between diet groups challenged with LPS. A lower 












Figure 11. Gut permeability measurements. Effect of diets on fluorescence levels after 
Sham or LPS challenge. An n=6 is assigned per group. Data are log10 transformed 
mean nanogram per milliliter. No significant differences in fluorescence levels were 
seen between any diets for LPS challenged mice.   
Serum Cytokines Analysis 
Sixteen different cytokines were analyzed which included: IL-1m IL-1, IL-
2, IL-3, IL-4, IL5, IL6, IL-10, IL-12p70, IL-17, MCP-1, IFN-, TNF-, MIP-1, GM-
CSF, and RANTES. Overall, LPS-challenged mice had a higher concentration of 
plasma cytokines amongst all diet groups compared to Sham mice. Diets that were 
predicted to reduce the production of pro-inflammatory cytokines (IL-1, IL-6, and 










Figure 12. Measurements of pro-inflammatory cytokines. Effect of dietary treatments 




assigned per group. No significant differences were seen for all 17 serum cytokines in 
LPS challenged mice.   
Discussion 
Intraperitoneal injection of LPS in a murine model is a method commonly used 
for inducing gastrointestinal leakiness and systemic inflammation through the 
production proinflammatory cytokines. It has been previously shown that certain 
dietary fats, milk fat and medium chain triglyceride oil, can protect against acute 
inflammation caused by LPS (Kono et al., 2003, Snow et al., 2011). Although these 
dietary fats came from two completely different sources, they both contain either one 
specific medium chain fatty acid (Caprylic C8:0) or a variety of short and medium chain 
fatty acids (C4-C14). For this study it was hypothesized that short and medium chain 
fatty acids in a purified diet will have a systemic protective effect against LPS. 
However, our results indicate that these dietary fatty acids had no protective effect 
against LPS in terms of survival, gut leakiness, or production of pro-inflammatory 
cytokines. The experiment was designed to clarify an unanswered question that arose 
in a previous study that suggested milk fat has a protective effect against 
gastrointestinal leakiness and resilience to acute inflammation/septic shock. As 
mentioned previously, it was unknown whether the milk fat globule membrane was the 
source of that protection or it the anhydrous milk fat. Thus, a separate anhydrous milk 
fat group was included in this study. At the same time, a diet that contained medium 
chain triglyceride oil was also included in this design to further explore the possibility 
that medium chain fatty acids could potentially be the reason to why these animals were 
resilient to LPS.  
Initially it was planned that a single study that involved the incorporation of 
dietary fats coming from corn oil, MCT oil, and milk fat would be conducted. However, 




was discovered that there was a formulation error in the milk fat diet. The milk fat diet 
was formulated to have a combination of MFGM and AMF, but CO was used instead. 
Therefore, mice study 1 did not evaluate the effects of MFGM+AMF but instead it 
looked at the effects of MFGM+CO during an inflammatory response. A separate single 
trial run with one experimental group was then conducted, with the same parameter as 
mice study 1, that had the correct milk fat formulation following mice study 1 (data not 
shown). Mice that were in this trial survived an LPS challenge. Along with the 
improvement in survival, the mice also had a lower concentration of serum FITC-
dextran and colon inflammatory score when compared to the experimental groups in 
mice study 1. The trial run gave merit for repeating the entire study with the correct 
diets. 
In mouse study 2, a few alterations to the original design were made. A fatty 
acid analysis of the previous MCT+CO diet indicated that both Caprylic (C8:0) and 
Capric (C10:0) were present in the diet. Previously, another study with an MCT diet 
containing only caprylic acid showed protective effects against LPS-induced shock. 
This protection involved the down regulation of the CD14 LPS binding receptor located 
on the surface of Kuppfer cell macrophages in the liver and alterations to intestinal 
permeability. Thus, an MCT+CO diet without Capric acid was used in the second study. 
After the finding from the colon histopathology from the trial experiment, we decided 
to evaluate the jejunum and ileum to see if similar effects would be seen in proximal 
region of the gastrointestinal tract. LPS also seemed to cause pathological changes in 
the liver in which necrotic and hemorrhagic changes can occur (Kono et al., 2003), thus 
segments of the liver were also taken for histopathological evaluation. In addition, a 
sham challenged group was included in the design, as a negative control, to observe 




 In the repeated study, LPS challenged mice did not survive regardless of diet 
treatment (Figure 10).  Mice were given purified diets for approximately the same 
timeframe as the preliminary study. Weight gain, feed efficiency, and body mass 
measurements indicated no significant differences between diet groups (Figure 8). 
Fasting glucose concentration along with calculated area for OGTT were not 
statistically different between diet group as well (Figure 9). LPS did influence gut 
barrier dysfunction in which hyper-permeability was seen in LPS challenged mice 
compared to the Sham (Figure 11). As expected, LPS challenged mice also had an 
increase of inflammatory cytokines when compared Sham mice (Figure 12). However, 
diets had no effect in preventing these negative effects from LPS.  
 The discrepancy in results from past results and published literature could have 
stemmed from multiple factors. For instance, in the referenced study in which MCT 
was shown to be effective in LPS challenged rats, the animals received capric acid 
through oral gavage at dosage of 5mg/kg once a day. The mechanism of delivery by 
oral gavage ensures that the test animals receive the required amount of dietary fats. 
For this study, diets contained approximately 5% fat by weight and by allowing the 
diets to be consumed ad libitum, mice were consuming less fat compared to the Kono 
study. Thus, the lower intake in MCT could explain the lethality of LPS at a dosage of 
10mg/kg. In the preliminary study, mice that were on the MFGM+AMF diet had a 
significantly higher feed efficiency relative to the other diet groups for both preliminary 
and repeated study, which indicates that these mice consumed more of the diet 
compared to the other groups. Mice in the secondary study were also group housed due 
to the large sample size, which can limit the amount of diet being consumed by each 






Ultimately, the results from this research indicate that short and medium chain 
fatty acids in a purified diet do not protect against acute inflammation induced by a 
high dose of LPS. The fatty acids did not attenuate the hyper-permeability of gut and 
release of the pro-inflammatory cytokines in LPS-challenged mice. Additionally, LPS 
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